Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/12/2019
SIETES contiene 92856 citas

 
 
 1 a 14 de 14 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]
2. Cita con resumen
Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]
3.Tiene citas relacionadas
Parfrey PS. Inhibitors of the renin-angiotensin systems: proven benefits, unproven safety. Ann Intern Med 2008;148:76-7. [Ref.ID 81946]
4.Tiene citas relacionadas Cita con resumen
5.Tiene citas relacionadas Cita con resumen
Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008;148:16-29. [Ref.ID 81943]
6.
Chrysant SG, Chrysant GS. Pharmacological and clinical profile of moexipril: a concise review. J Clin Pharmacol 2004;44:827-36. [Ref.ID 71161]
8.
Cawello W, Boekens H, Waitzinger J, Miller U. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition. Int J Clin Pharmacol Ther 2002;40:9-17. [Ref.ID 60140]
9. Cita con resumen
Sokol SI, Cheng A, Frishman WH, Kaza CS. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure. J Clin Pharmacol 2000;40:11-30. [Ref.ID 48842]
10. Cita con resumen
Anónimo. Drugs for hypertension. Med Lett Drugs Ther 1999;41:2328. [Ref.ID 44194]
11.
Anónimo. Moexipril - un onzième IEC pur l'HTA assez!. Prescrire 1998;18:645-7. [Ref.ID 40578]
12.
Brogden RN, Wiseman LR. Moexipril: a review of its use in the management of essential hypertension. Drugs 1998;55:845-60. [Ref.ID 38463]
13.
Miselli M, Zanfi D. Moexipril. Informazioni sui Farmaci 1998;22:3-4. [Ref.ID 38358]
14.
Anónimo. Moexipril: another ACE inhibitor for hypertension. Med Lett Drugs Ther 1995;37:75-6. [Ref.ID 24861]
Seleccionar todas
 
 1 a 14 de 14